Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D04OKJ
|
||||
Former ID |
DCL000334
|
||||
Drug Name |
Garenoxacin
|
||||
Synonyms |
T 3811; T-3811; T-3811MEa; BMS 284756 (*Mesylate salt*); BMS-284756 (*Mesylate salt*);1-Cyclopropyl-8-(difluoromethoxy)-7-[(1R)-(1-methyl-2,3-dihydro-1H-5-isoindolyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid; 1-cyclopropyl-8-(difluoromethoxy)-7-[(1R)-1-methyl-2,3-dihydro-1H-isoindol-5-yl]-4-oxoquinoline-3-carboxylic acid
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Endocarditis [ICD9: 421; ICD10:I33] | Terminated | [536094] | ||
Company |
Toyama Chemical
|
||||
Structure |
Download2D MOL |
||||
Formula |
C23H20F2N2O4
|
||||
Canonical SMILES |
CC1C2=C(CN1)C=C(C=C2)C3=C(C4=C(C=C3)C(=O)C(=CN4C5CC5)C(<br />=O)O)OC(F)F
|
||||
InChI |
1S/C23H20F2N2O4/c1-11-15-5-2-12(8-13(15)9-26-11)16-6-7-17-19(21(16)31-23(24)25)27(14-3-4-14)10-18(20(17)28)22(29)30/h2,5-8,10-11,14,23,26H,3-4,9H2,1H3,(H,29,30)/t11-/m1/s1
|
||||
InChIKey |
NJDRXTDGYFKORP-LLVKDONJSA-N
|
||||
CAS Number |
CAS 91421-42-0
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
629682, 10240978, 14782848, 14929713, 29304220, 50126319, 50198260, 57340754, 103500851, 104420046, 126681318, 126731325, 128709999, 134222367, 134338988, 135078604, 136367936, 136376435, 137211650, 142246907, 143496458, 144116000, 152059700, 152234926, 160821171, 162185570, 162263711, 162809937, 164023430, 164841947, 174476558, 174528172, 179150179, 198974823, 204431665, 223554218, 223663074, 223763968, 228243331, 249823130, 250203584, 251971067, 252058460, 252434392
|
||||
Target and Pathway | |||||
Target(s) | DNA topoisomerase II | Target Info | Inhibitor | [535226] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.